The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Amiodarone Market Research Report 2024

Global Amiodarone Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1886771

No of Pages : 90

Synopsis
Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.
The global Amiodarone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Amiodarone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amiodarone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amiodarone include Sanofi, Sawai Pharmaceutical, Wyeth Pharmaceuticals(Pfizer), Mylan Pharmaceuticals, Arrow Pharma Pty Ltd, Roemmers, Cipla Pharmaceutical, Shanghai Pharmaceuticals and North China Pharmaceutical Company, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Amiodarone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amiodarone.
Report Scope
The Amiodarone market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amiodarone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amiodarone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Sawai Pharmaceutical
Wyeth Pharmaceuticals(Pfizer)
Mylan Pharmaceuticals
Arrow Pharma Pty Ltd
Roemmers
Cipla Pharmaceutical
Shanghai Pharmaceuticals
North China Pharmaceutical Company
Harbin Pharmaceutical Group
Segment by Type
Tablet Amiodarone
Capsule Amiodarone
Injection Amiodarone
Segment by Application
Cardiac Arrest
Ventricular Tachycardia
Atrial Fibrillation
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amiodarone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amiodarone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Amiodarone Market Overview
1.1 Product Overview and Scope of Amiodarone
1.2 Amiodarone Segment by Type
1.2.1 Global Amiodarone Market Value Comparison by Type (2024-2030)
1.2.2 Tablet Amiodarone
1.2.3 Capsule Amiodarone
1.2.4 Injection Amiodarone
1.3 Amiodarone Segment by Application
1.3.1 Global Amiodarone Market Value by Application: (2024-2030)
1.3.2 Cardiac Arrest
1.3.3 Ventricular Tachycardia
1.3.4 Atrial Fibrillation
1.3.5 Others
1.4 Global Amiodarone Market Size Estimates and Forecasts
1.4.1 Global Amiodarone Revenue 2019-2030
1.4.2 Global Amiodarone Sales 2019-2030
1.4.3 Global Amiodarone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amiodarone Market Competition by Manufacturers
2.1 Global Amiodarone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amiodarone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amiodarone Average Price by Manufacturers (2019-2024)
2.4 Global Amiodarone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amiodarone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amiodarone, Product Type & Application
2.7 Amiodarone Market Competitive Situation and Trends
2.7.1 Amiodarone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amiodarone Players Market Share by Revenue
2.7.3 Global Amiodarone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amiodarone Retrospective Market Scenario by Region
3.1 Global Amiodarone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amiodarone Global Amiodarone Sales by Region: 2019-2030
3.2.1 Global Amiodarone Sales by Region: 2019-2024
3.2.2 Global Amiodarone Sales by Region: 2025-2030
3.3 Global Amiodarone Global Amiodarone Revenue by Region: 2019-2030
3.3.1 Global Amiodarone Revenue by Region: 2019-2024
3.3.2 Global Amiodarone Revenue by Region: 2025-2030
3.4 North America Amiodarone Market Facts & Figures by Country
3.4.1 North America Amiodarone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amiodarone Sales by Country (2019-2030)
3.4.3 North America Amiodarone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amiodarone Market Facts & Figures by Country
3.5.1 Europe Amiodarone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amiodarone Sales by Country (2019-2030)
3.5.3 Europe Amiodarone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amiodarone Market Facts & Figures by Country
3.6.1 Asia Pacific Amiodarone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amiodarone Sales by Country (2019-2030)
3.6.3 Asia Pacific Amiodarone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amiodarone Market Facts & Figures by Country
3.7.1 Latin America Amiodarone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amiodarone Sales by Country (2019-2030)
3.7.3 Latin America Amiodarone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amiodarone Market Facts & Figures by Country
3.8.1 Middle East and Africa Amiodarone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amiodarone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amiodarone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Amiodarone Sales by Type (2019-2030)
4.1.1 Global Amiodarone Sales by Type (2019-2024)
4.1.2 Global Amiodarone Sales by Type (2025-2030)
4.1.3 Global Amiodarone Sales Market Share by Type (2019-2030)
4.2 Global Amiodarone Revenue by Type (2019-2030)
4.2.1 Global Amiodarone Revenue by Type (2019-2024)
4.2.2 Global Amiodarone Revenue by Type (2025-2030)
4.2.3 Global Amiodarone Revenue Market Share by Type (2019-2030)
4.3 Global Amiodarone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Amiodarone Sales by Application (2019-2030)
5.1.1 Global Amiodarone Sales by Application (2019-2024)
5.1.2 Global Amiodarone Sales by Application (2025-2030)
5.1.3 Global Amiodarone Sales Market Share by Application (2019-2030)
5.2 Global Amiodarone Revenue by Application (2019-2030)
5.2.1 Global Amiodarone Revenue by Application (2019-2024)
5.2.2 Global Amiodarone Revenue by Application (2025-2030)
5.2.3 Global Amiodarone Revenue Market Share by Application (2019-2030)
5.3 Global Amiodarone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Amiodarone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Amiodarone Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Sawai Pharmaceutical
6.2.1 Sawai Pharmaceutical Corporation Information
6.2.2 Sawai Pharmaceutical Description and Business Overview
6.2.3 Sawai Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sawai Pharmaceutical Amiodarone Product Portfolio
6.2.5 Sawai Pharmaceutical Recent Developments/Updates
6.3 Wyeth Pharmaceuticals(Pfizer)
6.3.1 Wyeth Pharmaceuticals(Pfizer) Corporation Information
6.3.2 Wyeth Pharmaceuticals(Pfizer) Description and Business Overview
6.3.3 Wyeth Pharmaceuticals(Pfizer) Amiodarone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Wyeth Pharmaceuticals(Pfizer) Amiodarone Product Portfolio
6.3.5 Wyeth Pharmaceuticals(Pfizer) Recent Developments/Updates
6.4 Mylan Pharmaceuticals
6.4.1 Mylan Pharmaceuticals Corporation Information
6.4.2 Mylan Pharmaceuticals Description and Business Overview
6.4.3 Mylan Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Pharmaceuticals Amiodarone Product Portfolio
6.4.5 Mylan Pharmaceuticals Recent Developments/Updates
6.5 Arrow Pharma Pty Ltd
6.5.1 Arrow Pharma Pty Ltd Corporation Information
6.5.2 Arrow Pharma Pty Ltd Description and Business Overview
6.5.3 Arrow Pharma Pty Ltd Amiodarone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Arrow Pharma Pty Ltd Amiodarone Product Portfolio
6.5.5 Arrow Pharma Pty Ltd Recent Developments/Updates
6.6 Roemmers
6.6.1 Roemmers Corporation Information
6.6.2 Roemmers Description and Business Overview
6.6.3 Roemmers Amiodarone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Roemmers Amiodarone Product Portfolio
6.6.5 Roemmers Recent Developments/Updates
6.7 Cipla Pharmaceutical
6.6.1 Cipla Pharmaceutical Corporation Information
6.6.2 Cipla Pharmaceutical Description and Business Overview
6.6.3 Cipla Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla Pharmaceutical Amiodarone Product Portfolio
6.7.5 Cipla Pharmaceutical Recent Developments/Updates
6.8 Shanghai Pharmaceuticals
6.8.1 Shanghai Pharmaceuticals Corporation Information
6.8.2 Shanghai Pharmaceuticals Description and Business Overview
6.8.3 Shanghai Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shanghai Pharmaceuticals Amiodarone Product Portfolio
6.8.5 Shanghai Pharmaceuticals Recent Developments/Updates
6.9 North China Pharmaceutical Company
6.9.1 North China Pharmaceutical Company Corporation Information
6.9.2 North China Pharmaceutical Company Description and Business Overview
6.9.3 North China Pharmaceutical Company Amiodarone Sales, Revenue and Gross Margin (2019-2024)
6.9.4 North China Pharmaceutical Company Amiodarone Product Portfolio
6.9.5 North China Pharmaceutical Company Recent Developments/Updates
6.10 Harbin Pharmaceutical Group
6.10.1 Harbin Pharmaceutical Group Corporation Information
6.10.2 Harbin Pharmaceutical Group Description and Business Overview
6.10.3 Harbin Pharmaceutical Group Amiodarone Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Harbin Pharmaceutical Group Amiodarone Product Portfolio
6.10.5 Harbin Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amiodarone Industry Chain Analysis
7.2 Amiodarone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amiodarone Production Mode & Process
7.4 Amiodarone Sales and Marketing
7.4.1 Amiodarone Sales Channels
7.4.2 Amiodarone Distributors
7.5 Amiodarone Customers
8 Amiodarone Market Dynamics
8.1 Amiodarone Industry Trends
8.2 Amiodarone Market Drivers
8.3 Amiodarone Market Challenges
8.4 Amiodarone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’